Navigation Links
Treatment With VP20621 (Non-Toxigenic Clostridium difficile; NTCD) In A Phase 2 Study Resulted In High Rates Of Colonization And Statistically Significant Reductions In Recurrence Of C. difficile Infection
Date:4/22/2013

Dale N. Gerding , Professor of Medicine at Loyola University Chicago.

About Clostridium difficile
One of the most serious problems facing the U.S. healthcare system today is hospital-acquired infections (HAIs) and Clostridium difficile infection is one of the most common and devastating HAIs.  The incidence of C. difficile observed in U.S. healthcare facilities more than doubled approximately every five years since 1999 and the reported mortality rates from C. difficile in the U.S. have more than quadrupled in the last decade to 14,000 per year. Elderly patients exposed to antibiotics, long-term care patients, or those who have a serious underlying illness are at greatest risk to contract the disease. Typical symptoms include diarrhea (which can be severe), fever, nausea, abdominal pain, and dehydration that can lead to life-threatening complications such as shock, megacolon, peritonitis and perforation of the colon.

About ViroPharma Incorporated
ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options. ViroPharma is developing a portfolio of therapeutics for rare and Orphan diseases including C1 esterase inhibitor deficiency, Friedreich's Ataxia, and adrenal insufficiency; and recurrent C. difficile infection (CDI). Our goal is to provide rewarding careers to employees, to create new standards of care in the way serious diseases are treated, and to build international partnerships with the patients, advocates, and health care professionals we serve. ViroPharma's commercial products address diseases including hereditary angioedema (HAE), seizures and C. difficile-associated diarrhea (CDAD); for full U.S. prescribing information on our products, please download the p
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
8. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... WASHINGTON , July 30, 2015  Today we bring you a special edition ... wanted to remind you about some of our Medicare resources and continue highlighting the ... Check out our latest infographics and videos ... ... ...
(Date:7/30/2015)... VANCOUVER , July 30, 2015  OncoGenex Pharmaceuticals, ... will report its second quarter 2015 financial results on ... conference call and live webcast at 4:30 p.m. Eastern ... development programs and a general corporate update. ... Investor Relations page of the OncoGenex website at ...
(Date:7/30/2015)... PLAINFIELD, N.J., July 30, 2015 PTC Therapeutics, ... update and reported financial results for the second quarter ... progressing on many fronts across the organization.  We are ... Duchenne muscular dystrophy clinical trial ever conducted with topline ... Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. "Translarna ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10
... LOS ANGELES, Sept. 12, 2011 Cytta Corp (OTCQB: ... successfully completed the first client installation and deployment of ... Company to commence a full scale roll out of ... payors and providers, such as: Health Plans, Managed Care ...
... - Digital issue looks inside the ... The Journal of Emergency Medical Services ( ... four-volume digital issue featuring first-person accounts of responders who were ... 2001, when terrorists invaded their response districts - and their ...
Cached Medicine Technology:First Client Installation of CyttaConnect™ Medical Monitoring System 2First Client Installation of CyttaConnect™ Medical Monitoring System 3Out of the Darkness 2Out of the Darkness 3
(Date:7/31/2015)... ... 31, 2015 , ... Eldermark Software, the innovative leader of ... Services Technologies (CAST) Medication Management Technologies whitepaper. The whitepaper is a compilation of ... benefits of using medication management technologies . , Eldermark’s case ...
(Date:7/31/2015)... ... July 31, 2015 , ... ZH Healthcare announces a new cloud based ... HITaaS? Health IT as a Service (HITaaS) is a Healthcare dedicated cloud based service ... , HITaaS manages all aspects of infrastructure, security, runtime, middleware, OS, ...
(Date:7/31/2015)... ... ... Physical therapy for knee osteoarthritis is an important part of knee pain ... from doing what they want or need to do. The patient may have trouble getting ... patient's exercise regime may be limited by the pain in their knee. When a patient ...
(Date:7/31/2015)... ... ... New Energy Works Timberframers invites the public to join their timber frame hand-raising ... – 12pm. Timber frame raisings are special, celebrating both craft and shelter. ... of months of effort, planning, fundraising, and dreaming takes shape. , “There’s something ...
(Date:7/31/2015)... ... 2015 , ... The Radiology Business Management Association’s 2015 Fall ... for Health Care: A View From Capitol Hill” on Sunday, Sept. 27, 2015, in ... Rep. Burgess has a special understanding of the real world impact of health care ...
Breaking Medicine News(10 mins):Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3
... Thanks to an innovative program recently developed between Eastern ... Shield in Maine, some Anthem members in Bangor and Presque ... , As part of the pilot, Anthem members are able ... email with their provider about non-emergent issues, in addition to ...
... its Conjoint Mid-Winter Meetings Jan. 27Feb. 2, 2010, ... This year, SNM joins its annual Mid-Winter Educational ... Symposium of the American College of Nuclear Medicine ... the Clinical Trials Network Community Workshop. The seven-day ...
... ... firm Emergo Group recently surveyed medical device and IVD manufacturers, distributors and industry service ... 2010. , ... Texas (PRWEB) November 24, 2009 -- Global medical device regulatory consulting firm ...
... ... providing proven, non-surgical relief to millions of sufferers. , ... Dallas, TX (PRWEB) November 24, 2009 -- One-To-Zero ... Syndrome Diagnosis & Treatment seminar dates today. The three-day training seminars begin at ...
... , , SOMERSET, N.J., Nov. 24 ... healthcare and administrative staffing services, today announced that its application ... Nasdaq Global Market to The Nasdaq Capital Market has been ... opening of business on Wednesday, November 25, 2009, and the ...
... , COLUMBUS, Ga., Nov. 24 Aflac Incorporated ... Group plc has accepted the exchange of two of its investment ... Lloyds on November 3, 2009, and the exchanges are expected to ... will have exchanged its investment in Lloyds TSB Bank plc yen-denominated, ...
Cached Medicine News:Health News:The Doctor Will See You Now. . .Online 2Health News:SNM's Conjoint Mid-Winter Meetings offer 4 scientific meetings in 1 location 2Health News:Medical Device Industry Positive About 2010 – Survey 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 3Health News:TeamStaff Announces Transfer to Nasdaq Capital Market 2Health News:TeamStaff Announces Transfer to Nasdaq Capital Market 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 2Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 4Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 5
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Medicine Products: